Therefore, TZT could effectively control blood glucose in T2DM patients with Covid-19 through modulation of insulin sensitivity and pancreatic β cell function, which are highly deranged in severe Covid-19 (Ilias et al. 2021). This evidence concerns the gene INS and type 2 diabetes mellitus.